Estos frmacos incluyen semaglutida (Ozempic, Wegovy, Rybelsus), dulaglutida (Trulicity), liraglutida (Victoza, Saxenda), mientras que tirzepatida (Mounjaro, Zepbound) es un agonista dual GIP/GLP-1, no un agonista GLP-1 puro
95% of gastrointestinal (GI) related adverse events were reported as mild or moderate
2,3-BPG is a negative allosteric effector of the O 2 affinity of Hb
doi: 10.3390/molecules27061884 119 ScottMBStyringAKMcCullaghJSO
Watch to learn recommendations for incorporating an integrated home care model in health plan programs from Brendan Kerrigan and Dr
However, when compared to the GLP-1RAs, the SURPASS-2 trial results showed that tirzepatide reduced glycated hemoglobin and fasting serum glucose levels more than semaglutide at all dosages (5, 10, and 15 mg) [8]